Literature DB >> 17869381

NAP protects hippocampal neurons against multiple toxins.

Ilona Zemlyak1, Nathan Manley, Robert Sapolsky, Illana Gozes.   

Abstract

The femtomolar-acting protective peptide NAP (NAPVSIPQ), derived from activity-dependent neuroprotective protein (ADNP), is broadly neuroprotective in vivo and in vitro in cerebral cortical cultures and a variety of cell lines. In the present study, we have extended previous results and examined the protective potential of NAP in primary rat hippocampal cultures, using microtubule-associated protein 2 (MAP2) as a measure for neuroprotection. Results showed that NAP, at femtomolar concentrations, completely protected against oxygen-glucose deprivation, and cyanide poisoning. Furthermore, NAP partially protected against kainic acid excitotoxicity. In summary, we have significantly expanded previous findings in demonstrating here direct neuroprotective effects for NAP on vital hippocampal neurons that are key participants in cognitive function in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17869381     DOI: 10.1016/j.peptides.2007.08.004

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  12 in total

1.  Strategies to defeat ketamine-induced neonatal brain injury.

Authors:  C P Turner; S Gutierrez; C Liu; L Miller; J Chou; B Finucane; A Carnes; J Kim; E Shing; T Haddad; A Phillips
Journal:  Neuroscience       Date:  2012-02-23       Impact factor: 3.590

2.  Strategies for diminishing katanin-based loss of microtubules in tauopathic neurodegenerative diseases.

Authors:  Haruka Sudo; Peter W Baas
Journal:  Hum Mol Genet       Date:  2010-11-30       Impact factor: 6.150

3.  Brain delivery of NAP with PEG-PLGA nanoparticles modified with phage display peptides.

Authors:  Jingwei Li; Chi Zhang; Jing Li; Li Fan; Xinguo Jiang; Jun Chen; Zhiqing Pang; Qizhi Zhang
Journal:  Pharm Res       Date:  2013-04-03       Impact factor: 4.200

4.  Ultralow doses of dextromethorphan protect mice from endotoxin-induced sepsis-like hepatotoxicity.

Authors:  Ran Zhou; Shih-Heng Chen; Guorong Li; Hui-Ling Chen; YuXin Liu; Hung-Ming Wu; Yubao Wang; Jing Feng; Jau-Shyong Hong
Journal:  Chem Biol Interact       Date:  2019-02-26       Impact factor: 5.192

5.  Protein profiling reveals antioxidant and signaling activities of NAP (Davunetide) in rodent hippocampus exposed to hypobaric hypoxia.

Authors:  Niroj Kumar Sethy; Narendra Kumar Sharma; Mainak Das; Kalpana Bhargava
Journal:  J Mol Neurosci       Date:  2014-07-20       Impact factor: 3.444

6.  The neuroprotective peptide NAP does not directly affect polymerization or dynamics of reconstituted neural microtubules.

Authors:  Mythili Yenjerla; Nichole E LaPointe; Manu Lopus; Corey Cox; Mary Ann Jordan; Stuart C Feinstein; Leslie Wilson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

7.  NAP protects against cyanide-related microtubule destruction.

Authors:  Ilona Zemlyak; Robert Sapolsky; Illana Gozes
Journal:  J Neural Transm (Vienna)       Date:  2009-06-24       Impact factor: 3.575

Review 8.  PACAP and NAP: Effect of Two Functionally Related Peptides in Diabetic Retinopathy.

Authors:  Agata Grazia D'Amico; Grazia Maugeri; Giuseppe Musumeci; Dora Reglodi; Velia D'Agata
Journal:  J Mol Neurosci       Date:  2021-01-05       Impact factor: 3.444

9.  HP1 recruits activity-dependent neuroprotective protein to H3K9me3 marked pericentromeric heterochromatin for silencing of major satellite repeats.

Authors:  Kerstin Mosch; Henriette Franz; Szabolcs Soeroes; Prim B Singh; Wolfgang Fischle
Journal:  PLoS One       Date:  2011-01-18       Impact factor: 3.240

10.  Tau and caspase 3 as targets for neuroprotection.

Authors:  Anat Idan-Feldman; Regina Ostritsky; Illana Gozes
Journal:  Int J Alzheimers Dis       Date:  2012-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.